title: Colon targeting: an emerging frontier for oral insulin delivery.
abstract: Subcutaneous administration of insulin is associated with several limitations such as discomfort, local pain, irritation, infections, immune reactions and lipoatrophy as well as lipohypertrophy manifestations at the injection site. To overcome these drawbacks, enormous research is currently going on worldwide for designing of an alternative noninvasive route of administration. Pulmonary and oral route seem to be the most promising ones, with respect to the market value. However, after the letdown by pulmonary delivery of insulin, oral colon targeted delivery of insulin has gained tremendous interest among researchers. Although bioavailability remains a challenge for oral colon specific delivery of insulin, the employment of protease inhibitors, permeation enhancers and polymeric delivery systems have proved to be advantageous to overcome the said problem. This Editorial article is not intended to offer a comprehensive review on drug delivery, but shall familiarize the readers with the strategies employed for attaining non-erratic bioavailability of insulin, and to highlight some of the formulation technologies that have been developed for attaining oral colon-specific delivery of insulin.
authors.forename: Mayur Mahendrakumar
authors.initials: MM
authors.lastname: Patel
mesh_terms: D000284:Administration, Oral; D001682:Biological Availability; D003106:Colon / Q000187:drug effects*; D016503:Drug Delivery Systems; D006801:Humans; D007328:Insulin / Q000008:administration & dosage*
chemical_list: D007328:Insulin